NCT02390986View on ClinicalTrials.gov

An Extension Study of LON002 in Patients With Cancer

NAUnknownINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions

Solid Tumours

Interventions

DRUG

LON002

Extension study to provide continuing access to LON002 medication.

Trial Locations (2)

GU2 7XX

NOT_YET_RECRUITING

The Royal Surrey County Hospital, Guildford

SE1 9RT

RECRUITING

Guy's and St Thomas NHS Foundation Trust, London

Sponsors

Lead Sponsor

LondonPharma Ltd.

All Listed Sponsors

lead

LondonPharma Ltd.

INDUSTRY